Michael J. Ray
Special situations

Why Speculative Investors Can't Ignore Advanced Cell Technology

Investments in speculative biotech can cover lots of ground in the healthcare arena. From looking for a cure to cancer, all the way to weight management, there is a never ending supply of companies attempting to change the world of healthcare. Most are risky investments at best as these companies navigate through the maze or FDA regulations and clinical trials, while trying to keep their heads above water financially. This is where we find one special company named Advanced Cell Technology (ACTC.OB).

At first glance it does not seem to have much investment potential. With a current market capitalization of only $180 million, ACTC is definitely not an investment for the timid. That being the case, there are two critical...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details